Audiological and electrophysiological alterations in HIV-infected individuals subjected or not to antiretroviral therapy

被引:5
|
作者
Matas, Carla Gentile [1 ]
Samelli, Alessandra Giannella [1 ]
Leite Magliaro, Fernanda Cristina [1 ]
Segurado, Aluisio [2 ]
机构
[1] Univ Sao Paulo, Fac Med, Dept Fisioterapia Fonoaudiol & Terapia Ocupac, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Acquired immunodeficiency syndrome; Adults; Auditory evoked potentials; Hearing loss; HIV; HUMAN-IMMUNODEFICIENCY-VIRUS; HEARING-LOSS; AIDS; MANIFESTATIONS; OTOTOXICITY; IMPAIRMENT; POTENTIALS; DISEASE;
D O I
10.1016/j.bjorl.2017.07.003
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: The Human Immunodeficiency Virus (HIV) and infections related to it can affect multiple sites in the hearing system. The use of High Activity Anti-Retroviral Therapy (HAART) can cause side effects such as ototoxicity. Thus, no consistent patterns of hearing impairment in adults with Human Immunodeficiency Virus / Acquired Immune Deficiency Syndrome have been established, and the problems that affect the hearing system of this population warrant further research. Objectives: This study aimed to compare the audiological and electrophysiological data of Human Immunodeficiency Virus-positive patients with and without Acquired Immune Deficiency Syndrome, who were receiving High Activity Anti-Retroviral Therapy, to healthy individuals. Methods: It was a cross-sectional study conducted with 71 subjects (30-48 years old), divided into groups: Research Group I: 16 Human Immunodeficiency Virus-positive individuals without Acquired Immunodeficiency Syndrome (not receiving antiretroviral treatment); Research Group II: 25 Human Immunodeficiency Virus-positive individuals with Acquired Immunodeficiency Syndrome (receiving antiretroviral treatment); Control Group: 30 healthy subjects. All individuals were tested by pure-tone air conduction thresholds at 0.25-8 kHz, extended high frequencies at 9-20 kHz, electrophysiological tests (Auditory Brainstem Response, Middle Latency Responses, Cognitive Potential). Results: Research Group I and Research Group II had higher hearing thresholds in both conventional and high frequency audiometry when compared to the control group, prolonged latency of waves I, III, V and interpeak I-V in Auditory Brainstem Response and prolonged latency of P300 Cognitive Potential. Regarding Middle Latency Responses, there was a decrease in the amplitude of the Pa wave of Research Group II compared to the Research Group I. Conclusions: Both groups with Human Immunodeficiency Virus had higher hearing thresholds when compared to healthy individuals (group exposed to antiretroviral treatment showed the worst hearing threshold) and seemed to have lower neuroelectric transmission speed along the auditory pathway in the brainstem, subcortical and cortical regions. (C) 2018 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda.
引用
收藏
页码:574 / 582
页数:9
相关论文
共 50 条
  • [21] Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy
    Achenbach, Chad J.
    Cole, Stephen R.
    Kitahata, Mari M.
    Casper, Corey
    Willig, James H.
    Mugavero, Michael J.
    Saag, Michael S.
    AIDS, 2011, 25 (05) : 691 - 700
  • [22] Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
    Hogg, RS
    Heath, KV
    Yip, B
    Craib, KJP
    O'Shaughnessy, MV
    Schechter, MT
    Montaner, JSG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06): : 450 - 454
  • [23] Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy
    Cruse, Belinda
    Cysique, Lucette A.
    Markus, Romesh
    Brew, Bruce J.
    JOURNAL OF NEUROVIROLOGY, 2012, 18 (04) : 264 - 276
  • [24] Readiness for antiretroviral therapy: implications for linking HIV-infected individuals to care and treatment
    Maughan-Brown, B.
    Smith, P.
    Kuo, C.
    Harrison, A.
    Lurie, M.
    Bekker, L-G
    Galarraga, O.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20 : 18 - 19
  • [25] Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence
    Mannheimer, SB
    Matts, J
    Telzak, E
    Chesney, M
    Child, C
    Wu, AW
    Friedland, G
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2005, 17 (01): : 10 - 22
  • [26] Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy
    Paul, Robert
    Rhee, Gina
    Baker, Laurie M.
    Vaida, Florin
    Cooley, Sarah A.
    Ances, Beau M.
    JOURNAL OF NEUROVIROLOGY, 2017, 23 (05) : 725 - 733
  • [27] Readiness for Antiretroviral Therapy: Implications for Linking HIV-Infected Individuals to Care and Treatment
    Brendan Maughan-Brown
    Philip Smith
    Caroline Kuo
    Abigail Harrison
    Mark N. Lurie
    Linda-Gail Bekker
    Omar Galárraga
    AIDS and Behavior, 2018, 22 : 691 - 700
  • [28] Proteinuria is Associated With Neurocognitive Impairment in Antiretroviral Therapy Treated HIV-Infected Individuals
    Kalayjian, Robert C.
    Wu, Kunling
    Evans, Scott
    Clifford, David B.
    Pallaki, Muraldihar
    Currier, Judith S.
    Smryzynski, Marlene
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (01) : 30 - 35
  • [29] Recommendations for antiretroviral therapy in HIV-infected children
    Whan, V
    Bialek, R
    Böhler, T
    Funk, M
    Grosch-Wörner, I
    Horneff, G
    Notheis, G
    Wintergerst, U
    MONATSSCHRIFT KINDERHEILKUNDE, 1998, 146 (11) : 1081 - 1091
  • [30] Antiretroviral Therapy Changes in HIV-Infected Children
    M U Purswani
    R Johann-Liang
    J S Cervia
    G J Noel
    Pediatric Research, 1999, 45 : 171 - 171